Clinical trials
Myocardial Infarction clinical trials
Below are recruiting myocardial infarction clinical trials, each written for real people, not researchers. We’re tracking 318 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05248165Recruiting
Heart artery disease patients having stent placement
This study enrolls adults with blocked heart arteries who need a procedure called PCI (stent placement). It collects real-world information to help understand and improve care for people like you.
NaplesAges 18 years+ - NCT07137936Recruiting
Heart MRI Scar Study to Predict Sudden Cardiac Arrest Risk
This study uses a special heart MRI to look at scar tissue after a heart attack and see if it can help predict who might need a device to prevent sudden cardiac arrest. It is for people who had a heart attack at least a month ago and had a cardiac MRI at Anzhen Hospital.
BeijingAges 18–80 - NCT01372800Recruiting
Study blood adiponectin levels and stroke/heart risk
This study measures a blood marker called adiponectin and looks at how it relates to heart and stroke (cardiovascular and cerebrovascular) problems over time. It may help doctors understand who is at higher risk, especially in Chinese participants.
Xi'an, ShaanxiAges 18–85 - NCT07284576Enrolling by invitationPhase 2
Low-dose PET scan for heart imaging
This trial tests a very low dose of a radioactive tracer (18F-flurpiridaz) for PET scans of the heart. It aims to see if using less radiation still produces clear images, which may be safer for patients who need repeated scans.
Englewood, New JerseyAges 18–120 - NCT07293832Recruiting
Beta-blocker therapy for heart attack patients
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
Thessaloniki, ThessalonikiAges 18–80 - NCT07023679Recruiting
Stellate ganglion shot with morphine for heart attack patients
This study tests if a painkiller (morphine) injected near certain neck nerves can reduce damage to the heart muscle during a heart attack procedure. It is for people having a specific type of heart attack and who will get a stent to open the blocked artery.
HefeiAges 18 years+ - NCT06154395Recruiting
Improving heart blood flow after a first heart attack
This study tests a way to improve blood flow in the small vessels of the heart after a first heart attack. It is for people who have a specific type of heart attack in the front part of the heart and are treated quickly with a catheter procedure.
Harbin, HeilongjiangAges 18 years+ - NCT04939805Recruiting
Blood-cleaning treatment after first heart attack
This trial tests whether a blood-cleaning procedure called CRP apheresis, given after a first heart attack, can improve recovery when a heart-attack blood marker (CRP) is high. It’s aimed at people whose heart attack is treated quickly with a procedure to open blocked arteries, and who are well enough for heart MRI scans.
GrazAges 18–85 - NCT05111288Recruiting
Testing a pulse field therapy for reduced heart ischemia
This trial studies whether pulse electromagnetic field therapy can improve signs of reduced blood flow to the heart (ischemia) in people who cannot or will not get a coronary procedure during the study. If you already take standard heart medicines, you may be eligible to add this therapy and undergo exercise testing and heart imaging.
Scottsdale, ArizonaAges 18 years+ - NCT06947135Recruiting
Testing painkiller injection for heart attack patients
This trial tests if injecting a painkiller near neck nerves can reduce heart damage after a heart attack. It is for patients with a specific type of heart attack who are scheduled for a procedure to open blocked arteries.
Hefei, AnhuiAges 18 years+ - NCT02798276Recruiting
Procedure to improve heart scar tissue in certain adults
This trial studies a surgical technique that moves fat tissue to help heal or improve areas of scar in the heart. It may help people whose heart muscle scarring can’t be treated with opening blocked arteries.
Badalona, BarcelonaAges 18 years+ - NCT05476991RecruitingPhase 3
Low-dose colchicine plus ticagrelor to prevent repeat stroke
This Phase 3 study tests whether low-dose colchicine added to ticagrelor (a blood-thinning medicine) helps prevent another ischemic stroke in people whose first stroke was caused by clogged arteries. It aims to lower the risk of repeat stroke after recovery from a recent event.
Paris, ParisAges 18 years+ - NCT06910436Recruiting
AI timing and outcomes in heart attack study
This trial uses artificial intelligence to analyze ECG results and timing in patients with a type of heart attack called Non-STEMI (where the artery is narrowed but not fully blocked). The goal is to see if AI can help predict damage and outcomes, which could lead to better care.
Bolzano, BZAges 18 years+ - NCT06463808Recruiting
Heart recovery after heart attack with added protein therapy
This trial tests if adding a protein called rhBNP (which helps the heart relax) to standard care after a heart attack and stent improves heart recovery and pumping strength over time.
Nanjing, JiangsuAges 18–75 - NCT06548204RecruitingPhase 2
Antihistamine after a heart attack
This trial tests whether taking an antihistamine medicine called fexofenadine hydrochloride can help people recover better after a heart attack. It is a randomized study, so some participants will receive the medicine and others will receive a placebo (a pill with no active ingredients).
Hangzhou, ZhejiangAges 18 years+ - NCT04709900Recruiting
Tests for stable chest pain using heart scans and pressure measurements
This trial studies how well different heart tests (imaging the blood flow and measuring blood pressure in the heart) work for people with stable chest pain. It may help guide safer, more accurate evaluation when you are not having a heart attack.
CopenhagenAges Any age - NCT07268391Recruiting
Advanced scans to understand heart healing after heart attack
This study uses advanced CT scans and blood tests to look at how the heart is damaged and recovers after a first heart attack. It may help doctors find better ways to treat heart attacks in the future.
MadridAges 18 years+ - NCT07142265Recruiting
Early inclisiran after heart attack trial
This trial tests if giving inclisiran early after a heart attack can lower cholesterol more effectively. It is for people who have had a recent heart attack and still have high LDL cholesterol despite taking statins.
CheboksaryAges 18–100 - NCT07381803RecruitingPhase 3
Fexofenadine for heart attack recovery
This trial tests if the allergy medicine fexofenadine can improve recovery after a heart attack. You may qualify if you had a specific type of heart attack (STEMI) within the last week.
Hangzhou, ZhejiangAges 18 years+ - NCT05073419Recruiting
Test for heart rhythm issues after a heart attack
This trial checks how well a small heart monitor device can detect abnormal heart rhythms after a recent heart attack. It may help doctors catch rhythm problems early, which could improve follow-up care after discharge.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT04755387RecruitingPhase 4
Lower-dose blood thinner after heart attack stent
This trial looks at whether switching to a “lower-intensity” blood thinner plan after a heart attack and stent is safer and still works well. It may help reduce bleeding risk compared with a stronger approach, while protecting the stent from clots.
BusanAges 19–80 - NCT04619355Recruiting
People who had a special heart scan during stent placement
This study follows people who already had a stent put in (PCI) using a special imaging test (NIRS-IVUS) to look at heart outcomes over time. If you agreed and can attend follow-up visits, this registry may help doctors better understand how this imaging-guided approach performs.
SeoulAges 19 years+ - NCT06964685Recruiting
Impella heart pump in heart attack with shock
This study looks at how well the Impella CP heart pump works for people who have a severe heart attack that causes their heart to pump too weakly to keep blood flowing to their body. It's a registry that follows your care to improve best practices.
Jonesboro, ArkansasAges 18 years+ - NCT07626060Recruiting
AI Tools for Chest Pain Risk Assessment
This study tests whether artificial intelligence (AI) programs can accurately calculate a chest pain risk score to help doctors decide who needs urgent heart tests. You'll be monitored for 30 days to see if the AI's predictions were correct.
Istanbul, IstanbulAges 18 years+
Hear when a new Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for myocardial infarction?
- Yes. Clin2 currently lists 318 recruiting myocardial infarction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a myocardial infarction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a myocardial infarction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- STEMI - ST Elevation Myocardial Infarction
- ST Elevation Myocardial Infarction
- ST-segment Elevation Myocardial Infarction (STEMI)
- Cardiogenic Shock Post Myocardial Infarction
- Non-ST Elevation Myocardial Infarction
- Acute Myocardial Infarction With ST Elevation
- NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
- Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.